National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Urethral Cancer Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 01/09/2008



Purpose of This PDQ Summary






General Information






Cellular Classification






Stage Information






Anterior Urethral Cancer






Posterior Urethral Cancer






Urethral Cancer Associated With Invasive Bladder Cancer






Recurrent Urethral Cancer






Get More Information From NCI






Changes to This Summary (01/09/2008)






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Stage Information

Anterior Urethral Cancer
Posterior Urethral Cancer
Urethral Cancer Associated with Invasive Bladder Cancer
Stage Definitions by Depth of Invasion

Prognosis is determined both by the anatomical location of the neoplasm, the size, and the depth of invasion of the primary tumor. The histology of the primary tumor is of less importance in determining response to therapy and survival.[1]

Anterior Urethral Cancer

These lesions are often superficial.

  • Female: Meatal and/or distal urethral cancer (i.e., the lesions of the distal third of the urethra).
  • Male: Penile or anterior portion of the urethra, including the meatus and pendulous urethra.
Posterior Urethral Cancer

These lesions are often deeply invasive.

  • Female: Entire urethral cancer; lesions not clearly limited to the distal third of the urethra.
  • Male: Bulbomembranous and prostatic urethral cancer.
Urethral Cancer Associated with Invasive Bladder Cancer

Approximately 10% of patients with cystectomy for bladder cancer can be expected to have or develop urethral cancer distal to the urogenital diaphragm.

The 5-year survival associated with urethral cancer is most often determined by the stage.

Stage Definitions by Depth of Invasion
  • Stage 0 (Tis, Ta): Limited to mucosa.
  • Stage A (T1): Submucosal invasion.
  • Stage B (T2): Infiltrating periurethral muscle or corpus spongiosum.
  • Stage C (T3): Infiltration beyond periurethral tissue.
    • Female: Vagina, labia, muscle
    • Male: Corpus cavernosum, muscle
  • Stage D1 (N+): Regional nodes; pelvic and inguinal.
  • Stage D2 (N+, M+): Distant nodes; visceral metastases.

References

  1. Grigsby PW, Corn BW: Localized urethral tumors in women: indications for conservative versus exenterative therapies. J Urol 147 (6): 1516-20, 1992.  [PUBMED Abstract]

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov